Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Translational Science Center (TSC) is a specialized research and development unit within Merck KGaA (operating as EMD Serono in the U.S. and Canada). The center focuses on bridging the gap between early-stage discovery and clinical application by utilizing advanced biomarkers, genomics, and personalized medicine approaches. It plays a critical role in the development of the company's oncology and immunology pipelines, facilitating the identification of patient populations most likely to respond to specific therapies. The TSC integrates multi-omics data and clinical insights to accelerate the delivery of innovative medicines to patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Translational Science Center.